| Financial Year |
March 31 2023 |
| Monetary Funds |
1,497,763,969.13 |
| Held-for-trading Financial Assets |
50,171,780.82 |
| Notes Receivable |
2,718,130.50 |
| Accounts Receivable |
273,115,508.45 |
| Advances to Suppliers |
4,931,972.32 |
| Other Receivables |
5,846,217.09 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
287,567,010.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,700,255.43 |
| Total Current Assets |
2,192,328,264.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
86,028,748.88 |
| Investment Properties |
-- |
| Fixed Assetes |
66,673,473.91 |
| Under-construction Projects |
356,896,352.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
58,415,567.43 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
17,578,174.99 |
| Other Non-Current Assets |
40,802,971.44 |
| Sub-Total of Non-Current Assets |
626,395,288.92 |
| Total Assets |
2,818,723,553.59 |
| Short-Term Loans |
340,341,786.28 |
| Trading Financial liabilities |
-- |
| Notes Payable |
8,831,600.00 |
| Accounts Payable |
180,909,361.90 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,555,528.19 |
| Taxes Payable |
3,944,370.32 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
17,708,809.19 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
1,787,245.97 |
| Sub-Total of Current Liabilities |
619,356,760.99 |
| Long-term Loans |
-- |
| Bonds Payable |
272,470,747.93 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
7,040,254.57 |
| Deferred Income Tax Liabilities |
1,378,955.28 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
298,698,085.39 |
| Total Liabilities |
918,054,846.38 |
| Paid-In Capital(Or Share Stock) |
386,973,152.00 |
| Capital Surplus |
1,148,174,356.22 |
| Surplus Reserve |
52,482,734.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
266,110,691.31 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,900,668,707.21 |
| Owner's Equity（Stockholder's Equity） |
1,900,668,707.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,818,723,553.59 |
